Dr. Reddy’s Laboratories has launched the vital breast cancer treatment drug - Versavo (bevacizumab) in India.
It is biosimilar of the internationally used Avastin drug.
Biosimilarity means that the biological product is highly similar to the reference product not withstanding minor differences in clinically-inactive components.
There are no differences in terms of safety, purity, and potency of the product.